Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
NCT05541341
·
clinicaltrials.gov ↗
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Diffuse Large B-cell Lymphoma
Acute Lymphoblastic Leukemia
Follicular Lymphoma
Interventions
OTHER:
tisagenlecleucel
Sponsor
Novartis Pharmaceuticals